MECHANISM(S) OF EXCESS LDL OXIDATION IN DIABETES
MECHANISM(S) OF EXCESS LDL OXIDATION IN DIABETES
批准号:
6338890
负责人:
BALZ B FREI
金额:
$5.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-01 至 2001-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Diabetes is a common disorder associated with significant clinical
sequelae, including atherosclerosis. Up to three-fourths of all
deaths among diabetics are due to coronary heart disease (CHD) and
risk factors for CHD are particularly prevalent in diabetics.
Despite this observation, epidemiologic data suggest that
traditional risk factors for atherosclerosis explain only 25% of
the excess CHD in diabetes. This project is based on the
hypothesis that the increased incidence of CHD in diabetes is due,
in part, to accelerated atherogenic modification of low-density
lipoprotein (LDL) by oxidation. The objective of this project,
therefore, is to determine the mechanism(s) of excess LDL
oxidation in diabetes.
We will pursue this objective by examining the role in LDL
oxidation of two cardinal features of diabetes, hyperglycemia and
dyslipidemia. We will first characterize the effect(s) of glucose
on the LDL particle that may impair its resistance to oxidation.
Three different systems of LDL oxidation will be investigated:
metal ions (Cu2+, Fe3+), aqueous peroxyl radicals, and cultured
vascular cells in order to gain insight into the mechanism(s)
responsible for a glucose effect. Mechanism(s) will be identified
by measuring the effects of glucose on metal ion binding to and
reduction by LDL, and assessing the role of preformed lipid
hydroperoxides and specific reactive oxygen species in LDL
oxidation. We will next determine if known glucose-mediated
effects on vascular cell metabolism result in enhanced cellular
LDL oxidation. Effects of glucose on the cellular capacity to
modify LDL will be characterized by exploring relevant mechanisms
(i.e., cellular production of superoxide, nitric oxide [NO],
reduced thiol, and cellular reduction of transition metal ions)
and the signaling processes involved. Since vascular cell
dysfunction caused, in part, by oxidized LDL (ox-LDL) is also
important in the pathophysiology of atherosclerosis, we will
characterize the effect of glucose on specific cellular responses
to ox-LDL, including endothelial cell NO production and, monocyte
adhesion, and macrophage uptake of ox-LDL. In the final aim of
this project, we will investigate the effects of diabetes-related
dyslipidemia on LDL oxidation. Specifically, we will determine LDL
compositional changes that are associated with diabetic
dyslipidemia and relate these changes to LDL oxidative resistance.
Relevant findings from these experiments will be modeled using
reconstituted LDL to identify molecular mechanisms. In this
manner, we anticipate identifying the precise mechanism(s) of
excess LDL oxidation in diabetes, which may result in novel
treatments for diabetic vascular disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metal Chelators and thiols in Endothelial Function and CVD
-
批准号:7902737
-
项目类别:
-
资助金额:$45.97万
-
财政年份:2009
-
负责人:BALZ B FREI
-
依托单位:
Administrative Core
-
批准号:7902745
-
项目类别:
-
资助金额:$3.91万
-
财政年份:2009
-
负责人:BALZ B FREI
-
依托单位:
Administrative Core
-
批准号:7499214
-
项目类别:
-
资助金额:$56.73万
-
财政年份:2007
-
负责人:BALZ B FREI
-
依托单位:
Overall Program/Frei
-
批准号:7499144
-
项目类别:
-
资助金额:$60.59万
-
财政年份:2007
-
负责人:BALZ B FREI
-
依托单位:
CER on CAM Antioxidant Therapies (CERCAT)
-
批准号:7474322
-
项目类别:
-
资助金额:$116.04万
-
财政年份:2006
-
负责人:BALZ B FREI
-
依托单位:
11th Annual SFRBM Meeting
-
批准号:6887634
-
项目类别:
-
资助金额:$1.6万
-
财政年份:2004
-
负责人:BALZ B FREI
-
依托单位:
CER on CAM Antioxidant Therapies (CERCAT)
-
批准号:7070664
-
项目类别:
-
资助金额:$116.04万
-
财政年份:2003
-
负责人:BALZ B FREI
-
依托单位:
CER on CAM Antioxidant Therapies (CERCAT)
-
批准号:7641087
-
项目类别:
-
资助金额:$120.0万
-
财政年份:2003
-
负责人:BALZ B FREI
-
依托单位:
CER on CAM Antioxidant Therapies (CERCAT)
-
批准号:8075110
-
项目类别:
-
资助金额:$118.8万
-
财政年份:2003
-
负责人:BALZ B FREI
-
依托单位:
CER on CAM Antioxidant Therapies (CERCAT)
-
批准号:7810753
-
项目类别:
-
资助金额:$120.0万
-
财政年份:2003
-
负责人:BALZ B FREI
-
依托单位:
CER on CAM Antioxidant Therapies (CERCAT)
-
批准号:7241606
-
项目类别:
-
资助金额:$117.33万
-
财政年份:2003
-
负责人:BALZ B FREI
-
依托单位:
Metal Chelators and Thiols in Endothelial Function
-
批准号:6749789
-
项目类别:
-
资助金额:$116.1万
-
财政年份:2003
-
负责人:BALZ B FREI
-
依托单位:
CER on CAM Antioxidant Therapies (CERCAT)
-
批准号:6745396
-
项目类别:
-
资助金额:$116.1万
-
财政年份:2003
-
负责人:BALZ B FREI
-
依托单位:
Administrative Core
-
批准号:6749793
-
项目类别:
-
资助金额:$27.22万
-
财政年份:2003
-
负责人:BALZ B FREI
-
依托单位:
10th Annual SFRBM Meeting
-
批准号:6720050
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2003
-
负责人:BALZ B FREI
-
依托单位:
CER on CAM Antioxidant Therapies (CERCAT)
-
批准号:8294792
-
项目类别:
-
资助金额:$118.8万
-
财政年份:2003
-
负责人:BALZ B FREI
-
依托单位:
CER on CAM Antioxidant Therapies (CERCAT)
-
批准号:6904454
-
项目类别:
-
资助金额:$113.32万
-
财政年份:2003
-
负责人:BALZ B FREI
-
依托单位:
CER on CAM Antioxidant Therapies (CERCAT)
-
批准号:6805812
-
项目类别:
-
资助金额:$111.81万
-
财政年份:2003
-
负责人:BALZ B FREI
-
依托单位:
Vitamin C, glutathione, and endothelial cell activation
-
批准号:6658445
-
项目类别:
-
资助金额:$26.22万
-
财政年份:2002
-
负责人:BALZ B FREI
-
依托单位:
Vitamin C, glutathione, and endothelial cell activation
-
批准号:6496348
-
项目类别:
-
资助金额:$26.22万
-
财政年份:2001
-
负责人:BALZ B FREI
-
依托单位: